文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

在新墨西哥州的初级保健中筛查阿片类药物使用障碍以及共病的抑郁和创伤后应激障碍。

Screening for opioid use disorder and co-occurring depression and post-traumatic stress disorder in primary care in New Mexico.

机构信息

Department of Internal Medicine, Division of Epidemiology, Biostatistics and Preventive Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, 87131, USA.

Department of Medicine, Division of General Internal Medicine, School of Medicine, University of Pittsburgh, 200 Meyran Ave, Suite 300, Pittsburgh, PA, 15213, USA.

出版信息

Addict Sci Clin Pract. 2023 Jan 27;18(1):6. doi: 10.1186/s13722-023-00362-5.


DOI:10.1186/s13722-023-00362-5
PMID:36707910
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9881516/
Abstract

BACKGROUND: Identifying patients in primary care services with opioid use disorder and co-occurring mental health disorders is critical to providing treatment. Objectives of this study were to (1) assess the feasibility of recruiting people to screen in-person for opioid use disorder and co-occurring mental health disorders (depression and/or post-traumatic stress disorder) in primary care clinic waiting rooms in preparation for a randomized controlled trial, and (2) compare results of detecting these disorders by universal in-person screening compared to electronic health record (EHR) diagnoses. METHODS: This cross-sectional feasibility and pilot study recruited participants from four primary care clinics, two rural and two urban, from three health care organizations in New Mexico. Inclusion criteria were adults (≥ 18 years), attending one of the four clinics as a patient, and who spoke English or Spanish. Exclusion criteria were people attending the clinic for a non-primary care visit (e.g., dental, prescription pick up, social support). The main outcomes and measures were (1) recruitment feasibility which was assessed by frequencies and proportions of people approached and consented for in-person screening, and (2) relative differences of detecting opioid use disorder and co-occurring mental health disorders in waiting rooms relative to aggregate EHR data from each clinic, measured by prevalence and prevalence ratios. RESULTS: Over two-weeks, 1478 potential participants were approached and 1145 were consented and screened (77.5% of patients approached). Probable opioid use disorder and co-occurring mental health disorders were identified in 2.4% of those screened compared to 0.8% in EHR. Similarly, universal screening relative to EHR identified higher proportions of probable opioid use disorder (4.5% vs. 3.4%), depression (17.5% vs. 12.7%) and post-traumatic stress disorder (19.0% vs. 3.6%). CONCLUSIONS: Universal screening for opioid use disorder, depression, and post-traumatic stress disorder was feasible, and identified three times as many patients with these co-occurring disorders compared to EHR. Higher proportions of each condition were also identified, especially post-traumatic stress disorder. Results support that there are likely gaps in identification of these disorders in primary care services and demonstrate the need to better address the persistent public health problem of these co-occurring disorders.

摘要

背景:在初级保健服务中识别出患有阿片类药物使用障碍和并发精神健康障碍(抑郁和/或创伤后应激障碍)的患者对于提供治疗至关重要。本研究的目的是:(1)评估在初级保健诊所候诊室中对阿片类药物使用障碍和并发精神健康障碍(抑郁和/或创伤后应激障碍)进行现场筛查以准备进行随机对照试验的可行性,以及(2)比较通过普遍现场筛查与电子健康记录(EHR)诊断来检测这些疾病的结果。

方法:这项横断面可行性和试点研究从新墨西哥州三个医疗保健组织的四个初级保健诊所招募参与者,其中两个位于农村,两个位于城市。纳入标准为成年人(≥18 岁),作为患者之一到四个诊所中的一个就诊,并且会讲英语或西班牙语。排除标准为来诊所就诊的人是非初级保健就诊(例如,牙科、取药、社会支持)。主要结局和措施为:(1)通过接触和同意进行现场筛查的人数和比例来评估招募的可行性,以及(2)通过每个诊所的综合 EHR 数据检测到的阿片类药物使用障碍和并发精神健康障碍的相对差异,通过患病率和患病率比来衡量。

结果:在两周内,接触了 1478 名潜在参与者,其中 1145 名同意并接受了筛查(接受筛查的患者占 77.5%)。与 EHR 相比,在接受筛查的患者中发现了 2.4%的可能患有阿片类药物使用障碍和并发精神健康障碍,而 EHR 中为 0.8%。同样,与 EHR 相比,普遍筛查发现可能患有阿片类药物使用障碍(4.5%比 3.4%)、抑郁(17.5%比 12.7%)和创伤后应激障碍(19.0%比 3.6%)的比例更高。

结论:普遍筛查阿片类药物使用障碍、抑郁和创伤后应激障碍是可行的,与 EHR 相比,它识别出了三倍以上同时患有这些共病的患者。每种疾病的比例也更高,尤其是创伤后应激障碍。结果表明,在初级保健服务中,这些疾病的识别可能存在差距,并表明需要更好地解决这些共病的持续公共卫生问题。

相似文献

[1]
Screening for opioid use disorder and co-occurring depression and post-traumatic stress disorder in primary care in New Mexico.

Addict Sci Clin Pract. 2023-1-27

[2]
Pharmacotherapy for anxiety and comorbid alcohol use disorders.

Cochrane Database Syst Rev. 2015-1-20

[3]
Psychological therapies for post-traumatic stress disorder and comorbid substance use disorder.

Cochrane Database Syst Rev. 2016-4-4

[4]
Cannabis use, risk of cannabis use disorder, and anxiety and depression among bisexual patients: A comparative study of sex and sexual identity differences in a large health system.

Drug Alcohol Depend. 2025-6-20

[5]
Psychological therapies for women who experience intimate partner violence.

Cochrane Database Syst Rev. 2020-7-1

[6]
Consultation liaison in primary care for people with mental disorders.

Cochrane Database Syst Rev. 2015-9-18

[7]
Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults.

Cochrane Database Syst Rev. 2015-3-5

[8]
Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: Systematic review and component network meta-analysis.

PLoS Med. 2020-8-19

[9]
Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults.

Cochrane Database Syst Rev. 2016-3-12

[10]
Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness.

Cochrane Database Syst Rev. 2017-1-24

引用本文的文献

[1]
Opioid use disorder medications among youth in primary care: Subgroup analysis of the PROUD trial.

Pediatr Open Sci. 2025

[2]
Trauma exposure correlates among patients receiving care in federally qualified health centers.

J Trauma Stress. 2024-12

[3]
Trauma exposure across the lifespan among individuals engaged in treatment with medication for opioid use disorder: differences by gender, PTSD status, and chronic pain.

Subst Abuse Treat Prev Policy. 2024-5-3

[4]
Trauma Exposure Across the Lifespan among Individuals Engaged in Treatment with Medication for Opioid Use Disorder: Differences by Gender, PTSD Status, and Chronic Pain.

Res Sq. 2023-12-19

本文引用的文献

[1]
Emergency Department Visits for Nonfatal Opioid Overdose During the COVID-19 Pandemic Across Six US Health Care Systems.

Ann Emerg Med. 2022-2

[2]
Multidisciplinary treatment of opioid use disorder in primary care using the collaborative care model.

Subst Abus. 2022

[3]
Comparison of Methods for Alcohol and Drug Screening in Primary Care Clinics.

JAMA Netw Open. 2021-5-3

[4]
Design of CLARO (Collaboration Leading to Addiction Treatment and Recovery from other Stresses): A randomized trial of collaborative care for opioid use disorder and co-occurring depression and/or posttraumatic stress disorder.

Contemp Clin Trials. 2021-5

[5]
Trends in US Emergency Department Visits for Mental Health, Overdose, and Violence Outcomes Before and During the COVID-19 Pandemic.

JAMA Psychiatry. 2021-4-1

[6]
Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic - United States, June 24-30, 2020.

MMWR Morb Mortal Wkly Rep. 2020-8-14

[7]
Screening for Unhealthy Drug Use: Neither an Unreasonable Idea Nor an Evidence-Based Practice.

JAMA. 2020-6-9

[8]
Mental Health and Psychosocial Needs of Patients Being Treated for Opioid Use Disorder in a Primary Care Residency Clinic.

J Prim Care Community Health. 2020

[9]
PTSD and opioid use: implications for intervention and policy.

Subst Abuse Treat Prev Policy. 2020-3-16

[10]
Prevalence of documented alcohol and opioid use disorder diagnoses and treatments in a regional primary care practice-based research network.

J Subst Abuse Treat. 2020-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索